5 completed, 2 unknown, 1 not yet recruiting. 8 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Completed 5, Unknown 2, Not yet recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Solvents: new trials by email Literature Review of Solvents trials Research Report on Solvents
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intravenous Alpha-1 Antitrypsin for Hospitalized Patients With COPD Exacerbations (AECOPD Study) alpha1-proteinase inhibitor, produced from the plasma of human donors (Prolastin 1000 mg, powder and solvent for solution for infusion), Placebo - Acute Exacerbation Chronic Obstructive Pulmonary Disease | Phase 2 | Not yet recruiting | Fondazione IRCCS Policlinico San Matteo di Pavia | 36 | 2025-10-01 | 2025-08-24 |
| Study of the Safety, Reactogenicity and Immunogenicity of "EpiVacCorona" Vaccine for the Prevention of COVID-19 EpiVacCorona (EpiVacCorona vaccine based on peptide antigens for the prevention of COVID-19), Placebo (sodium chloride bufus, solvent for the preparation of dosage forms for injection 0.9%) - Covid19 | Phase 1 / Phase 2 | Completed | Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector" | 100 | 2020-07-27 | 2022-03-16 |
| A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Children GlaxoSmithKline (GSK) Biologicals' investigational recombinant chimpanzee adenovirus Type 3-vectored Ebola Zaire vaccine (ChAd3-EBO-Z) (GSK3390107A), Nimenrix powder and solvent for solution for injection in pre-filled syringe; Meningococcal group A, C, W-135 and Y conjugate vaccine - Virus Diseases | Phase 2 | Completed | GlaxoSmithKline | 600 | 2015-11-09 | 2018-05-03 |
| The Arterial Measurement of the Blood Flow Volume After Iloprost Stimulation Ilomedin - Diabetes, Arteriosclerosis | Phase 2 | Unknown | Prim PD Dr Afshin Assadian | 100 | 2012-10-01 | 2018-10-17 |
| Pharmacokinetics of Hydrocortisone After Subcutaneous Administration in Chronic Adrenal Insufficiency Hydrocortisone intramuscular first, Hydrocortisone subcutaneously first - Primary Adrenal Insufficiency | Phase 2 | Completed | Bruno Allolio | 12 | 2011-11-01 | 2012-08-01 |
| Evaluation of Safety/Efficacy of Diagnostic Skin Test Panel and Desensitization Hormone Kit for Treatment of Premenstrual Syndrome (PMS) Skin test panel and desensitization kit, Skin test panel and solvent - Premenstrual Syndrome | Phase 2 | Unknown | EVE Medical Systems Ltd. | 20 | 2009-04-01 | 2010-06-16 |
| Fibrin Sealant for the Sealing of Dura Sutures Fibrin Sealant, Vapor Heated, Solvent/Detergent-treated with 500 IU/mL thrombin and synthetic aprotinin (FS VH S/D 500 s-apr), Standard of care - Pathological Processes in the Posterior Fossa, Dura Defects | Phase 2 | Completed | Baxter Healthcare Corporation | 95 | 2008-05-01 | 2013-06-27 |
| Safety, Pharmacokinetic and Efficacy Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Patients With Primary Immunodeficiency (Hypo- or Agammaglobulinemia) Immune Globulin Intravenous (Human), 10% TVR (Triple Virally Reduced) Solution, Gammagard S/D (Solvent/Detergent) - Primary Immunodeficiency Diseases (PID), Agammaglobulinemia | Phase 2 | Completed | Baxalta now part of Shire | 24 | 2002-06-13 | 2021-08-24 |
Addison Disease (1) · Adrenal Insufficiency (1) · Agammaglobulinemia (1) · Arteriosclerosis (1) · COVID-19 (1) · Diabetes Mellitus (1) · Peripheral Arterial Occlusive Disease 1 (1) · Premenstrual Syndrome (1) · Primary Immunodeficiency Diseases (1) · Virus Diseases (1)
Baxalta now part of Shire (1) · Baxter Healthcare Corporation (1) · Bruno Allolio (1) · EVE Medical Systems Ltd. (1) · Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector" (1) · Fondazione IRCCS Policlinico San Matteo di Pavia (1) · GlaxoSmithKline (1) · Prim PD Dr Afshin Assadian (1)
Austria (1) · Canada (1) · Finland (1) · Germany (1) · Israel (1) · Italy (1) · Mali (1) · Russia (1) · Senegal (1) · Sweden (1) · United States (1)
Afshin Assadian, Prim PD Dr (1) · Guenter Zuelow, MD (1) · Jacob Cohen, Dr. (1) · Shmuel Kivity, Prof. (1) · Stefanie Hahner, MD (1) · Vladimir I. Kuzubov (1)
PMID 10465169, PMID 10933492, PMID 11148177, PMID 11874817, PMID 12045122, PMID 12740257, PMID 12826636, PMID 15050036, PMID 15683545, PMID 18565211, PMID 19197072, PMID 19553648, PMID 19845686, PMID 20843247, PMID 21060150, PMID 21367592, PMID 21486454, PMID 21680942, PMID 22123804, PMID 22447964, PMID 22634722, PMID 23526215, PMID 23672956, PMID 23975926, PMID 23989916, PMID 25299856, PMID 26026936, PMID 26282478, PMID 26304913, PMID 27564664, PMID 27916480, PMID 28404617, PMID 29719508, PMID 30237305, PMID 30965011, PMID 31179005, PMID 32060059, PMID 32199492, PMID 3261353, PMID 33069326, PMID 33288475, PMID 33961754, PMID 34570991, PMID 3494198, PMID 35291694, PMID 36462509, PMID 37568109, PMID 38074132, PMID 38108968, PMID 7693853
2014 (1)